Alternative splicing of the TNFSF13B (BAFF) pre-mRNA and expression of the BAFFX1 isoform in human immune cells.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 Nov 2020
Historique:
received: 14 04 2020
revised: 18 06 2020
accepted: 30 07 2020
pubmed: 9 8 2020
medline: 2 10 2020
entrez: 9 8 2020
Statut: ppublish

Résumé

Human B cell activating factor (TNFSF13B, BAFF) is a tumor necrosis factor superfamily member. Binding its unique receptor (TNFRSF13C, BAFF-R) mediates gene expression and cell survival in B cells via activation of NFκB pathway. Furthermore, there is data indicating a role in T cell function. A functionally inhibitory isoform (ΔBAFF) resulting from the deletion of exon 3 in the TNFSF13B pre-RNA has already been reported. However, data on the complexity of post-transcriptional regulation is scarce. Here, we report molecular cloning of nine TNFSF13B transcript variants resulting from alternative splicing of the TNFSF13B pre-mRNA including BAFFX1. This variant is characterized by a partial retention of intron 3 of the TNFSF13B gene causing the appearance of a premature stop codon. We demonstrate the expression of the corresponding BAFFX1 protein in Jurkat T cells, in ex vivo human immune cells and in human tonsillar tissue. Thereby we contribute to the understanding of TNFSF13B gene regulation and reveal that BAFF is regulated through a post-transcriptional mechanism to a greater extent than reported to date.

Identifiants

pubmed: 32763489
pii: S0378-1119(20)30690-9
doi: 10.1016/j.gene.2020.145021
pii:
doi:

Substances chimiques

B-Cell Activating Factor 0
NF-kappa B 0
Protein Isoforms 0
RNA Precursors 0
TNFSF13B protein, human 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145021

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Patrick Stelmach (P)

Department of Neurology, Philipps-University Marburg, Marburg, Germany; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.

Michael Pütz (M)

Department of Neurology, Philipps-University Marburg, Marburg, Germany; Max-Planck-Institute for Terrestrial Microbiology, Marburg, Germany.

Robert Pollmann (R)

Department of Dermatology, Philipps-University Marburg, Marburg, Germany.

Michael Happel (M)

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

Susanne Stei (S)

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

Kerstin Schlegel (K)

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

Maria Seipelt (M)

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

Christian Eienbröker (C)

Department of Neurology, Philipps-University Marburg, Marburg, Germany.

Rüdiger Eming (R)

Department of Dermatology, Philipps-University Marburg, Marburg, Germany.

Robert Mandic (R)

Department of Otolaryngology/Head and Neck Surgery, Philipps-University Marburg, Marburg, Germany.

Magdalena Huber (M)

Department of Medical Microbiology, Philipps-University Marburg, Marburg, Germany.

Björn Tackenberg (B)

Department of Neurology, Philipps-University Marburg, Marburg, Germany; F. Hoffmann-La Roche Ltd, Basel, Switzerland. Electronic address: tackenbb@staff.uni-marburg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH